Published in Proc Natl Acad Sci U S A on November 25, 2002
Plasma urate and risk of Parkinson's disease. Am J Epidemiol (2007) 3.06
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol (2008) 2.79
Promoting axonal rewiring to improve outcome after stroke. Neurobiol Dis (2009) 1.77
Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol (2008) 1.68
Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view. Antioxid Redox Signal (2011) 1.32
Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease. Clin Exp Nephrol (2005) 1.27
Uric acid protects against secondary damage after spinal cord injury. Proc Natl Acad Sci U S A (2005) 1.24
Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier. J Virol (2007) 1.18
Inosine augments the effects of a Nogo receptor blocker and of environmental enrichment to restore skilled forelimb use after stroke. J Neurosci (2011) 1.14
Pathophysiological roles for purines: adenosine, caffeine and urate. Prog Brain Res (2010) 1.13
Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia. PLoS One (2010) 1.09
Inosine alters gene expression and axonal projections in neurons contralateral to a cortical infarct and improves skilled use of the impaired limb. J Neurosci (2009) 1.06
Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models. Proc Natl Acad Sci U S A (2007) 1.05
Association of serum uric acid and incident nonspine fractures in elderly men: the Osteoporotic Fractures in Men (MrOS) study. J Bone Miner Res (2014) 0.97
Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes. Mol Med (2003) 0.93
Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go? Purinergic Signal (2012) 0.88
Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis. Front Cell Neurosci (2013) 0.86
Serum uric acid levels and neuromyelitis optica. J Neurol (2010) 0.84
Glutamate-stimulated peroxynitrite production in a brain-derived endothelial cell line is dependent on N-methyl-D-aspartate (NMDA) receptor activation. Biochem Pharmacol (2006) 0.83
Serum uric acid levels in multiple sclerosis patients inversely correlate with disability. Neurol Sci (2011) 0.79
Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson's disease. Brain Res (2014) 0.78
Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study. J Neurol (2015) 0.78
Mechanisms of action of therapeutic amyloidogenic hexapeptides in amelioration of inflammatory brain disease. J Exp Med (2014) 0.78
Inosine enhances axon sprouting and motor recovery after spinal cord injury. PLoS One (2013) 0.78
Serum uric acid levels in patients with Alzheimer's disease: a meta-analysis. PLoS One (2014) 0.77
Gelam honey scavenges peroxynitrite during the immune response. Int J Mol Sci (2012) 0.77
Protection by inosine in a cellular model of Parkinson's disease. Neuroscience (2014) 0.75
Targeting urate to reduce oxidative stress in Parkinson disease. Exp Neurol (2017) 0.75
Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity. Sci Rep (2017) 0.75
Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys (1992) 3.68
Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol (1992) 2.35
Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A (1998) 2.21
Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol (1994) 1.95
Inosine induces axonal rewiring and improves behavioral outcome after stroke. Proc Natl Acad Sci U S A (2002) 1.88
Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J (2000) 1.75
Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci U S A (1995) 1.70
Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys (2000) 1.62
Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock. J Immunol (2000) 1.47
Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation. Arch Biochem Biophys (1999) 1.44
Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci U S A (1997) 1.42
A reassessment of the peroxynitrite scavenging activity of uric acid. Ann N Y Acad Sci (2002) 1.26
Protection against peroxynitrite-dependent tyrosine nitration and alpha 1-antiproteinase inactivation by ascorbic acid. A comparison with other biological antioxidants. Free Radic Res (1996) 1.25
Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction. Eur J Neurol (2002) 1.23
The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent. J Immunol (2001) 1.14
Peroxynitrite formation within the central nervous system in active multiple sclerosis. J Neuroimmunol (1998) 1.13
Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease. Mult Scler (2001) 1.11
Prospects for the treatment of multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitrite. Ann Neurol (2001) 1.11
Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury. Ann Surg (2002) 1.07
Inosine reduces systemic inflammation and improves survival in septic shock induced by cecal ligation and puncture. Am J Respir Crit Care Med (2001) 1.05
Uricase protein sequences: conserved during vertebrate evolution but absent in humans. FASEB J (1988) 1.04
Effect of inosine supplementation on aerobic and anaerobic cycling performance. Med Sci Sports Exerc (1996) 1.01
Molecular evolution of the urate oxidase-encoding gene in hominoid primates: nonsense mutations. Gene (1991) 1.01
Uric acid levels in patients with multiple sclerosis: analysis in mono- and dizygotic twins. Mult Scler (2001) 1.00
Uric acid levels in sera from patients with multiple sclerosis. J Neurol (2001) 0.93
Protection of myelin basic protein immunized mice from free-radical mediated inflammatory cell invasion of the central nervous system by the natural peroxynitrite scavenger uric acid. Neurosci Lett (2000) 0.92
Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis. Eur Neurol (1992) 0.91
Anti-inflammatory effects of inosine in human monocytes, neutrophils and epithelial cells in vitro. Int J Mol Med (2001) 0.90
Taste-active components in some foods: a review of Japanese research. Physiol Behav (1991) 0.86
Effect of inosine supplementation on 3-mile treadmill run performance and VO2 peak. Med Sci Sports Exerc (1990) 0.85
Oxonate-induced hyperuricemia and orotic aciduria in mice. Proc Soc Exp Biol Med (1978) 0.78
Increased concentrations of uric acid in the spinal cord of rats with chronic relapsing experimental allergic encephalomyelitis. Neurosci Lett (1986) 0.77
Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J Immunol (2006) 1.94
Rabies transmission from organ transplants in the USA. Lancet (2004) 1.92
CD28 costimulation is essential for human T regulatory expansion and function. J Immunol (2008) 1.86
Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin. J Immunol (2008) 1.71
Hibernator Citellus undulatus maintains safe cardiac conduction and is protected against tachyarrhythmias during extreme hypothermia: possible role of Cx43 and Cx45 up-regulation. Heart Rhythm (2005) 1.55
The treatment of multiple sclerosis with inosine. J Altern Complement Med (2009) 1.48
Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection. J Virol (2006) 1.42
Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proc Natl Acad Sci U S A (2004) 1.41
Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells. PLoS One (2011) 1.39
Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus. Proc Natl Acad Sci U S A (2009) 1.34
Tobacco as a production platform for biofuel: overexpression of Arabidopsis DGAT and LEC2 genes increases accumulation and shifts the composition of lipids in green biomass. Plant Biotechnol J (2009) 1.34
Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs. Clin Immunol (2010) 1.30
A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient. J Immunol (2007) 1.29
Uric acid protects against secondary damage after spinal cord injury. Proc Natl Acad Sci U S A (2005) 1.24
Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier. J Virol (2007) 1.18
A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies. J Gen Virol (2005) 1.17
Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc Natl Acad Sci U S A (2003) 1.16
Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity. Proc Natl Acad Sci U S A (2008) 1.14
Effects of treatments on inflammatory and apoptotic markers in the CNS of mice with globoid cell leukodystrophy. Brain Res (2009) 1.12
Immune evasion by rabies viruses through the maintenance of blood-brain barrier integrity. J Neurovirol (2008) 1.10
Inhibition of tumor growth by plant-derived mAb. Proc Natl Acad Sci U S A (2005) 1.08
Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers. Clin Cancer Res (2013) 1.07
Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies. J Infect Dis (2003) 1.07
Comparison of uric acid and ascorbic acid in protection against EAE. Free Radic Biol Med (2002) 1.05
Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models. Proc Natl Acad Sci U S A (2007) 1.05
The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation. J Pharmacol Exp Ther (2004) 0.99
Poly(ADP-ribose) polymerase activity contributes to peroxynitrite-induced spinal cord neuronal cell death in vitro. J Neurotrauma (2004) 0.96
Rabies virus nucleoprotein as a carrier for foreign antigens. Proc Natl Acad Sci U S A (2004) 0.94
Plant biopharming of monoclonal antibodies. Virus Res (2005) 0.92
Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells. Proc Natl Acad Sci U S A (2006) 0.92
ICAM-1 upregulation in the spinal cords of PLSJL mice with experimental allergic encephalomyelitis is dependent upon TNF-alpha production triggered by the loss of blood-brain barrier integrity. J Neuroimmunol (2004) 0.91
Circadian variation in oxidative stress markers in healthy and type II diabetic men. Chronobiol Int (2002) 0.91
Elimination of alkaloids from plant-derived human monoclonal antibody. J Immunol Methods (2004) 0.91
Severe acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccine. Proc Natl Acad Sci U S A (2005) 0.91
Smallpox subunit vaccine produced in Planta confers protection in mice. Proc Natl Acad Sci U S A (2007) 0.90
Intracellular reprogramming of expression, glycosylation, and function of a plant-derived antiviral therapeutic monoclonal antibody. PLoS One (2013) 0.89
Plant based HIV-1 vaccine candidate: Tat protein produced in spinach. Vaccine (2005) 0.89
Plant-derived EpCAM antigen induces protective anti-cancer response. Cancer Immunol Immunother (2007) 0.88
Controlled glycosylation of therapeutic antibodies in plants. Arch Biochem Biophys (2004) 0.87
Peroxynitrite-induced oligodendrocyte toxicity is not dependent on poly(ADP-ribose) polymerase activation. Glia (2003) 0.86
Therapeutic immune clearance of rabies virus from the CNS. Future Virol (2011) 0.86
The role of toll-like receptors in the induction of immune responses during rabies virus infection. Adv Virus Res (2011) 0.85
Rabies virus clearance from the central nervous system. Adv Virus Res (2011) 0.85
Temporal changes in innate immune signals in a rat model of alcohol withdrawal in emotional and cardiorespiratory homeostatic nuclei. J Neuroinflammation (2012) 0.84
Differential expression of growth factors at the cellular level in virus-infected brain. Proc Natl Acad Sci U S A (2003) 0.83
Early blood-brain barrier permeability in cerebella of PLSJL mice immunized with myelin basic protein. J Neuroimmunol (2008) 0.83
Immunization with a plant-produced colorectal cancer antigen. Cancer Immunol Immunother (2003) 0.80
Expression of a human anti-rabies virus monoclonal antibody in tobacco cell culture. Biochem Biophys Res Commun (2006) 0.79
Combination nonviral interleukin 2 gene therapy and external-beam radiation therapy for head and neck cancer. Arch Otolaryngol Head Neck Surg (2003) 0.79
Role of uric acid in Alzheimer's disease. J Alzheimers Dis (2010) 0.78
Glioblastoma exosomes and IGF-1R/AS-ODN are immunogenic stimuli in a translational research immunotherapy paradigm. Cancer Immunol Immunother (2014) 0.78
Aleuria Aurantia Lectin (AAL)-reactive immunoglobulin G rapidly appears in sera of animals following antigen exposure. PLoS One (2012) 0.78
Substance P enhances HIV-1 infection in human fetal brain cell cultures expressing full-length neurokinin-1 receptor. J Neurovirol (2013) 0.78
Inhibition of hypochlorous acid-induced cellular toxicity by nitrite. Proc Natl Acad Sci U S A (2002) 0.77
Serum and cerebrospinal fluid uric acid levels in multiple sclerosis patients. Clin Neurol Neurosurg (2008) 0.77
Enhancement of glioma-specific immunity in mice by "NOBEL", an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide. Cancer Immunol Immunother (2015) 0.77
Immunogenic properties of plant-derived recombinant smallpox vaccine candidate pB5. Vaccine (2008) 0.76
Plant-produced hepatitis B core protein chimera carrying anthrax protective antigen domain-4. Hybridoma (Larchmt) (2008) 0.76
Screening of organ and tissue donors for rabies. Lancet (2005) 0.75
Reactive oxygen/nitrogen species at the fulcrum of life-death decisions: a commentary on "peroxynitrite transforms nerve growth factor into an apoptotic factor for motor neurons". Free Radic Biol Med (2006) 0.75
Pathogenesis of Alfalfa mosaic virus in Soybean (Glycine max) and Expression of Chimeric Rabies Peptide in Virus-Infected Soybean Plants-A Reexamination. Phytopathology (2002) 0.75